Neuropsychiatric Symptoms in Alzheimer's Disease: Associations with Beta Amyloid and Potential New Cutoff Points on Neuropsychiatric Assessment Scales
Neuropsychiatric Symptoms (NPS) have been shown to be associated with Alzheimer's disease ( AD). They negatively affect disease outcome and could play a future role in the detection of prospective AD cases. In the present study we aimed at examining the rel ation between NPS and Amyloid beta ( in both a cognitively healthy N = and cognitively impaired N = 224) dataset from the Swedish BioFINDE